Docking Prediction for Luteolin Inhibiting TNF-α and NF-κB Pathway

E-ISSN： 1875-628x|9|2|169-176

ISSN： 1570-1808

Source： Letters in Drug Design & Discovery, Vol.9, Iss.2, 2012-02, pp. : 169-176

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The NF-κB signalling pathway: a therapeutic target in lymphoid malignancies?

By Stoffel Archontoula

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 5, 2005-10 ,pp. : 1045-1061

Informa Healthcare

Access to resources Recommend Favorite

TNF-α/NF-κB Signaling in the CNS: Possible Connection to EPHB2

By Pozniak Paul White Martyn Khalili Kamel

Journal of Neuroimmune Pharmacology, Vol. 9, Iss. 2, 2014-03 ,pp. : 133-141

Springer Publishing Company

Access to resources Recommend Favorite

Naringin Inhibits TNF- Induced Oxidative Stress and Inflammatory Response in HUVECs via Nox4/NF-Κ B and PI3K/Akt Pathways

Current Pharmaceutical Biotechnology, Vol. 15, Iss. 12, 2014-12 ,pp. : 1173-1182

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the TNF-α pathway in sarcoidosis

By Antoniu Sabina A

Expert Opinion on Therapeutic Targets, Vol. 14, Iss. 1, 2010-01 ,pp. : 21-29

Informa Healthcare

Access to resources Recommend Favorite

The role of NF-κB in 6-hydroxydopamine- and TNFα-induced apoptosis of PC12 cells

By Tarabin Victoria Schwaninger Markus

Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 369, Iss. 6, 2004-06 ,pp. : 563-569

Springer Publishing Company

Access to resources Recommend Favorite